Home / Import refusals / SCS-4191232-1/11/1

FDA Import Refusal SCS-4191232-1/11/1 — Cayman Chemical Company, Inc.

Cayman Chemical Company, Inc. — FEI 3002715502

The FDA refused shipment SCS-4191232-1/11/1 from Cayman Chemical Company, Inc. (United States) on May 7, 2019. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 2 other import refusals on record.

Refusal Details

Date
May 7, 2019
Country
United States
Product Category
Drugs and Biologics
Product Code
66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1267154 (VAI Thu Apr 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1074100 (VAI Mon Dec 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904339 (VAI Wed Nov 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 820205 (VAI Thu Feb 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 759917 (VAI Thu Dec 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AEK-5857229-6/11/1 (Fri Nov 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-2769476-1/11/1 (Wed Dec 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Human Foods)

FDA data resources